Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 55 Records) |
| Query Trace: Neoplasms and CXCL12[original query] |
|---|
| Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2014 Aug 26 1-7. Rebbani Khadija, Ezzikouri Sayeh, Marchio Agnès, Ababou Mostafa, Kitab Bouchra, Dejean Anne, Kandil Mostafa, Pineau Pascal, Benjelloun Souma |
| Examining the polymorphisms in the hypoxia pathway genes in relation to outcome in colorectal cancer. PloS one 2014 9 (11): e113513. Haja Mohideen Asan M S, Hyde Angela, Squires Jessica, Wang Jing, Dicks Elizabeth, Younghusband Ban, Parfrey Patrick, Green Roger, Savas Sevt |
| The CXCL12 G801A polymorphism is associated with cancer risk: a meta-analysis. PloS one 2014 9 (9): e108953. Zhu Ke, Jiang Benchun, Hu Rong, Yang Ying, Miao Miao, Li Yingchun, Liu Zhuoga |
| CXCL12 rs266085 and TNF-a rs1799724 polymorphisms and susceptibility to cervical cancer in a Chinese population. International journal of clinical and experimental pathology 2015 8 (5): 5768-74. Yin Geping, Zhu Tongyu, Li Juan, Wu Aifang, Liang Jing, Zhi Yuanyu |
| CXCL12 G801A polymorphism and cancer risk: An updated meta-analysis. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2015 Jun 35 (3): 319-26. Meng Dan, Wu Yin-Xiang, Heerah Vidhi, Peng Shuang, Chu Meng-di, Xu Yong-Jian, Xiong Wei-Ning, Xu Shu-Y |
| CCR2-64I polymorphism is associated with Non-Small Cell Lung Cancer in Tunisian patients. Human immunology 2015 May 76 (5): 348-54. Rafrafi Ahlem, Kaabachi Safa, Kaabachi Wajih, Chahed Besma, Amor Amira Ben, Mbarik Marwa, Charrad Rihab, Salah Marwa Ouled, Hamzaoui Kamel, Sassi Fayçal H |
| CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma. OncoTargets and therapy 2015 8 2835-42. Chen Ruiwan, Xu Yafei, Du Xiaojing, Liu Na, Li Yingqin, He Qingmei, Tang Linglong, Mao Yanping, Sun Ying, Chen Lei, Ma J |
| CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy. The pharmacogenomics journal 2016 Aug . Matsusaka S, Cao S, Hanna D L, Sunakawa Y, Ueno M, Mizunuma N, Zhang W, Yang D, Ning Y, Stintzing S, Sebio A, Stremitzer S, Yamauchi S, Parekh A, Okazaki S, Berger M D, El-Khoueiry R, Mendez A, Ichikawa W, Loupakis F, Lenz H |
| Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues. Oncology letters 2016 Mar 11 (3): 1873-1878. Allami Risala Hussain, Graf Claudine, Martchenko Ksenia, Voss Beatrice, Becker Marc, Berger Martin R, Galle Peter R, Theobald Matthias, Wehler Thomas C, Schimanski Carl |
| Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and in-silico expression analysis of CXCL12-CXCR4 associated biological regulatory network. PeerJ 2017 5 e3822. Khalid Samra, Hanif Rume |
| Lack of Association of the Fat Mass and Obesity Associated (FTO) Gene rs9939609 Polymorphism with Breast Cancer Risk: a Systematic Review and Meta-Analysis Based on Case - Control Studies Asian Pacific journal of cancer prevention : APJCP 2017 04 18 (4): 1031-1037. Jafari Nedooshan Jamal, Kargar Saeed, Neamatzadeh Hossein, Haghighi Fatemeh, Dehghani Mohammad Abadi Reihaneh, Seddighi Niloof |
| CXCR4-CXCL12-CXCR7, TLR2-TLR4, and PD-1/PD-L1 in colorectal cancer liver metastases from neoadjuvant-treated patients. Oncoimmunology 2016 5 (12): e1254313. D'Alterio Crescenzo, Nasti Guglielmo, Polimeno Marianeve, Ottaiano Alessandro, Conson Manuel, Circelli Luisa, Botti Giovanni, Scognamiglio Giosuè, Santagata Sara, De Divitiis Chiara, Nappi Anna, Napolitano Maria, Tatangelo Fabiana, Pacelli Roberto, Izzo Francesco, Vuttariello Emilia, Botti Gerardo, Scala Stefan |
| CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer. Molecular biology reports 2018 Jun . Guembarovski Alda Losi, Guembarovski Roberta Losi, Hirata Bruna Karina Banin, Vitiello Glauco Akelinghton Freire, Suzuki Karen Mayumi, Enokida Mayara Tiemi, Watanabe Maria Angelica Ehara, Reiche Edna Maria Visso |
| The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis. OncoTargets and therapy 2018 11 2445-2452. Xu Ke, Dai Hong, Wang Shaolong, Zhang Jie, Liu T |
| Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis. Journal of cancer research and therapeutics 2018 3 14 (2): 345-350. Dayer Reza, Babashah Sadegh, Jamshidi Shirin, Sadeghizadeh Maj |
| rs12416605:C>T in MIR938 associates with gastric cancer through affecting the regulation of the CXCL12 chemokine gene. Molecular genetics & genomic medicine 2019 7 7 (8): e832. Torruella-Loran Ignasi, Ramirez Viña María Karla, Zapata-Contreras Daniela, Muñoz Xavier, Garcia-Ramallo Eva, Bonet Catalina, Gonzalez Carlos A, Sala Núria, Espinosa-Parrilla Yolanda, |
| Correlation between Chemokine CXCL-12 and ist Receptor CXCR4 Expression is Associated with Clinical Prognosis of Gastric Cancer. Clinical laboratory 2020 Apr 66 (4): . Xu Gang, Lu Ke, Shen Minghai, Zhang Qinghua, Pan Wanneng, Tang Zhongz |
| Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer. Bioscience reports 2020 4 40 (4): . Lv Jia, Zhu Yongze, Ji Alin, Zhang Qi, Liao Guodo |
| Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients. Applied immunohistochemistry & molecular morphology : AIMM 2020 Jan . Ottaiano Alessandro, Scala Stefania, Normanno Nicola, Botti Gerardo, Tatangelo Fabiana, Di Mauro Annabella, Capozzi Monica, Facchini Sergio, Tafuto Salvatore, Nasti Gugliel |
| Role of CXCL12, TP53 and CYP1A1 gene polymorphisms in susceptibility to pediatric acute lymphoblastic leukemia. Oncology letters 2021 Sep 22 (3): 659. Kampouraki Eleni, Lourou Marilena, Zervou Maria I, Ampazoglou Evangelia-Dimitra, Yachnakis Emmanuel, Katzilakis Nikolaos, Goulielmos George N, Stiakaki Eftich |
| Pan-cancer analysis of CXCR4 carcinogenesis in human tumors. Translational cancer research 2022 2 10 (9): 4180-4195. Wang Sen, Wang Lin, Chen Si-W |
| CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis. Journal of cancer research and clinical oncology 2022 Jan . Okuyama Nádia Calvo Martins, Cezar-Dos-Santos Fernando, Trugilo Kleber Paiva, Esposito Aline, Guembarovski Roberta Losi, Couto-Filho José d'Oliveira, Watanabe Maria Angelica Ehara, de Oliveira Karen Braj |
| Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study. Molecular biology reports 2022 Mar 49 (3): 2255-2263. Lin Shuai, Zheng Yi, Wang Meng, Zhou Linghui, Zhu Yuyao, Deng Yujiao, Wu Ying, Zhang Dai, Li Na, Kang Huafeng, Dai Zhij |
| Allelic variants and immunostaining profile in CXCL12/CXCR4 axis: An investigation of association with prognosis in prostate cancer. Pathology, research and practice 2023 9 250 154806. Amanda Letícia Francelino, Érica Romão Pereira, Laís Capelasso Lucas Pinheiro, Adrielli Caroline Soares, Ana Carla Mendonça, Paulo Emílio Fuganti, Wilson Frantine-Silva, Karen Brajão de Oliveira, Juliana Mara Serpeloni, Roberta Losi Guembarovs |
| Gene Variations of Chemokine and Chemokine Receptor CXCL12/CXCR4 in Lung Cancer. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2023 2 42 (2): 49-57. Ozbayer Cansu, Yagci Emine, Ak Guntulu, Metintas Selma, Metintas Muzaffer, Kurt Huly |
| Identification of molecular subtypes and a risk model based on inflammation-related genes in patients with low grade glioma. Heliyon 2023 12 9 (12): e22429. Cheng Long, Ya Song, Yimin Pan, Changwu |
| Computed tomography-detected extramural venous invasion-related gene signature: a potential negative biomarker of immune checkpoint inhibitor treatment in patients with gastric cancer. Journal of translational medicine 2023 1 21 (1): 4. Yang Hao, Gou Xinyi, Feng Caizhen, Zhang Yinli, Chai Fan, Hong Nan, Ye Yingjiang, Wang Yi, Gao Bo, Cheng J |
| DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome. Clinical epigenetics 2024 7 16 (1): 89. Flavia Lima Costa Faldoni, Daniela Bizinelli, Cristiano Pádua Souza, Iara Viana Vidigal Santana, Márcia Maria Chiquitelli Marques, Claudia Aparecida Rainho, Fabio Albuquerque Marchi, Silvia Regina Rogat |
| Association of the SNPs in CCL2 and CXCL12 genes with the susceptibility to breast cancer: a case-control study in China. Frontiers in oncology 2024 12 14 1475979. Duanchong Zhao, Xingxing Yu, Hongli Huang, Shuqing Zou, Pingxiu Zhu, Yuxiang Lin, Mengjie Song, Fangmeng Fu, Haomin Ya |
| An immune gene expression risk score for distant metastases after radiotherapy for cervical cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 1 . Jelena Lukovic, Melania Pintilie, Kathy Han, Anthony W Fyles, Jeff P Bruce, Rene Quevedo, Trevor J Pugh, Christina S Fjeldbo, Heidi Lyng, Michael F Milosev |
- Page last reviewed:Feb 1, 2024
- Content source: